≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Iridocyclitis in diseases classified elsewhere

DOID EFO Endpoint Browser PheWeb

H7_IRIDOCYCLITISINOTH

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H22[0-1]
  • Cause of death: ICD-10 — H22[0-1]

2 out of 7 registries used, show all original rules.

812

4. Check minimum number of events

None

812

5. Include endpoints

None

812

6. Filter based on genotype QC (FinnGen only)

718

Control definitions (FinnGen only)

Control exclude
H7_SCLERACORNEA

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3920 2066 1843
Only index persons 3697 1955 1742
Unadjusted period prevalence (%)
Whole population 0.06 0.06 0.05
Only index persons 0.07 0.07 0.07
Median age at first event (years)
Whole population 53.62 55.44 51.59
Only index persons 53.59 55.89 51.00

-FinnGen-

Key figures

All Female Male
Number of individuals 718 402 316
Unadjusted period prevalence (%) 0.14 0.14 0.14
Median age at first event (years) 56.84 55.96 57.96

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
754
Matched controls
7540
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
15.6
313.0
360
417
M45
ICD-10 Finland
Ankylosing spondylitis
80.3
307.7
230
41
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2231.6
307.7
356
*
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
37.5
301.2
196
70
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
34.0
261.0
174
66
H22.1*M45
ICD-10 Finland
Iridocyclitis in ankylosing spondylitis
+∞
259.9
234
*
L04AX03
ATC
methotrexate; systemic
13.3
253.7
305
367
S01AD03
ATC
aciclovir; ophthalmic
31.0
239.2
164
67
L04AB04
ATC
adalimumab; parenteral
34.9
234.9
154
55
A07EC01
ATC
sulfasalazine; oral, rectal
13.5
229.4
258
279
S01BA04
ATC
prednisolone; ophthalmic
40.5
227.4
142
43
H22.0*B02.3
ICD-10 Finland
Zoster iridocyclitis
+∞
225.7
205
*
H20.1
ICD-10 Finland
Chronic iridocyclitis
+∞
216.4
197
*
S01BA01
ATC
dexamethasone; ophthalmic
22.2
197.1
154
86
L01BA01
ATC
methotrexate; systemic
19.9
182.4
150
93
S01ED51
ATC
timolol, combinations; ophthalmic
10.6
160.6
205
257
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic
78.7
156.3
84
12
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
10.1
143.0
186
237
S01FA04
ATC
cyclopentolate; ophthalmic
57.9
137.7
78
15
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
9.1
127.1
178
247
H22.0*B00.5
ICD-10 Finland
Herpesviral iridocyclitis
+∞
124.5
116
*
S01ED01
ATC
timolol; ophthalmic
17.1
124.5
108
73
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
39.7
116.6
72
20
L04AB01
ATC
etanercept; parenteral
27.5
113.7
79
32
H22.1*D86.8
ICD-10 Finland
Iridocyclitis in sarcoidosis
+∞
110.2
103
*
L04AB06
ATC
golimumab; parenteral
46.5
101.2
60
14
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
30.5
100.4
67
24
H19.2*B02.3
ICD-10 Finland
Keratitis and keratoconjunctivitis (interstitial) in zoster
+∞
97.0
91
*
H26.2
ICD-10 Finland
Complicated cataract
32.6
96.5
63
21
J05AB11
ATC
valaciclovir; oral
5.2
91.3
248
652
L88
ICPC
Rheumatoid/seropositive arthritis
10.4
85.3
101
111
J05AB01
ATC
aciclovir; systemic
4.4
82.4
308
1029
L04AA13
ATC
[U] leflunomide
14.7
82.1
76
57
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
4.2
81.4
476
2176
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
+∞
79.6
75
*
H22.1
ICD-10 Finland
Iridocyclitis in other diseases classified elsewhere
+∞
75.3
71
*
H16.0
ICD-10 Finland
Corneal ulcer
13.5
69.2
67
54
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.0
67.2
256
850
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
19.6
67.0
53
29
S01EA05
ATC
brimonidine; ophthalmic
13.1
66.8
66
55
S01BA07
ATC
fluorometholone; ophthalmic
19.5
64.3
51
28
H02AB06
ATC
prednisolone; systemic
3.7
63.6
502
2648
S01EA03
ATC
apraclonidine; ophthalmic
25.1
63.2
45
19
D86.0
ICD-10 Finland
Sarcoidosis of lung
16.2
61.1
53
35
B02.3
ICD-10 Finland
Zoster ocular disease
224.8
61.1
62
*
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
22.7
60.8
45
21
S01EC01
ATC
acetazolamide; systemic
12.0
59.5
62
56
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
162.7
57.8
60
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
4.1
57.3
192
575
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
3.3
57.0
362
1640
L04AX01
ATC
azathioprine; systemic
7.1
54.4
87
136
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.6
54.2
147
374
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
11.0
53.5
59
58
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
16.4
52.4
45
29
114
Kela drug reimbursment
Glaucoma
4.9
52.0
130
309
S01BC03
ATC
diclofenac; ophthalmic
12.1
49.6
51
45
P01BA02
ATC
hydroxychloroquine; oral
4.8
48.8
124
298
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
83.1
48.6
54
7
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
4.3
47.5
143
392
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
16.8
47.2
40
25
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.0
46.2
353
1729
B02.9
ICD-10 Finland
Zoster without complication
4.8
44.7
110
257
H02AB07
ATC
prednisone; oral
3.6
43.5
172
569
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
16.2
42.8
37
24
H22.0
ICD-10 Finland
Iridocyclitis in infectious and parasitic diseases classified elsewhere
441.4
42.6
42
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
42.3
462
2692
H30.2
ICD-10 Finland
Posterior cyclitis
155.5
42.2
44
*
H16.9
ICD-10 Finland
Keratitis, unspecified
81.7
41.4
46
6
H221, M084,
ICD-10 Finland
+∞
41.0
39
*
H57.1
ICD-10 Finland
Ocular pain
6.5
40.4
69
115
L04AA01
ATC
[U] ciclosporin
14.6
38.4
35
25
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.7
37.8
308
1523
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
385.5
37.3
37
*
B00.5
ICD-10 Finland
Herpesviral ocular disease
105.5
37.1
40
*
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
102.7
36.1
39
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
4.6
35.9
92
221
H04.10
ICD-10 Finland
Dry eye syndrome
3.5
35.6
140
457
S01EE01
ATC
latanoprost; ophthalmic
4.7
35.6
88
205
S01FA02
ATC
scopolamine; ophthalmic
60.2
34.5
40
7
7200A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis
52.7
33.8
40
8
S01EC04
ATC
brinzolamide; ophthalmic
5.5
30.0
60
116
CJB10
NOMESCO Finland
Laser discission of secondary cataract
3.8
29.3
98
286
Z3229
NOMESCO Finland
Other healthcare associate professional
3.6
29.0
104
318
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.9
28.7
93
265
H221, M083,
ICD-10 Finland
+∞
28.3
27
*
L04AB05
ATC
certolizumab pegol; parenteral
39.5
27.3
34
9
H19.1
ICD-10 Finland
Herpesviral keratitis and keratoconjunctivitis
280.6
26.9
27
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.3
26.5
72
180
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
9.8
26.3
31
33
WZA10
NOMESCO Finland
Extensive medical or dental certificate
8.6
26.3
34
41
H20.8
ICD-10 Finland
Other iridocyclitis
+∞
26.2
25
*
M13.9
ICD-10 Finland
Arthritis, unspecified
3.5
25.1
93
290
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
40.3
25.0
31
8
H40.0
ICD-10 Finland
Glaucoma suspect
3.5
25.0
92
285
H26.4
ICD-10 Finland
After-cataract
3.2
24.9
108
371
ZXA10
NOMESCO Finland
Bilateral
2.6
24.2
178
812
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.9
23.6
129
506
L04AA11
ATC
[U] etanercept
37.6
23.1
29
8
S01EE04
ATC
travoprost; ophthalmic
7.9
23.1
32
42
XCK10
NOMESCO Finland
Photography of fundus of eye
3.1
21.9
101
359
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
226.3
21.7
22
*
A02BC02
ATC
pantoprazole; systemic
2.2
21.4
550
4112
ZXE00
NOMESCO Finland
One hour or less
2.1
21.4
326
2003
H25.1
ICD-10 Finland
Senile nuclear cataract
2.2
21.1
233
1262
71240
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica
61.9
21.0
24
*
H26.3
ICD-10 Finland
Drug-induced cataract
20.1
21.0
31
16
XCK00
NOMESCO Finland
Perimetry
3.8
20.9
67
189
H20
ICD-10 Finland
Iridocyclitis
49.5
20.3
24
5
L04AA17
ATC
[U] adalimumab
41.3
19.6
24
6
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
5.6
19.2
37
69
B02.8
ICD-10 Finland
Zoster with other complications
20.7
19.2
28
14
TCF00
NOMESCO Finland
Subconjunctival therapeutic injection
71.8
18.8
21
*
WX140
NOMESCO Finland
Parabulbar anesthesy
4.0
18.6
55
146
N03AX16
ATC
[U] pregabalin
2.2
18.5
202
1082
S01EE05
ATC
tafluprost; ophthalmic
4.4
18.4
48
116
M01AH01
ATC
celecoxib; oral
2.3
18.2
161
789
132
Kela drug reimbursment
Sarcoidosis
17.0
18.0
28
17
3640A
ICD-9 Finland
Disorders of iris and ciliary body, Acute and subacute iridocyclitis
+∞
17.8
17
*
H03.1*B02.3
ICD-10 Finland
Zoster blepharitis
32.3
17.1
22
7
CG2S4
NOMESCO Finland
Photography of cornea
64.9
16.8
19
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.6
16.7
103
426
36400
ICD-8 Finland
Iritis, Iridocyclitis acuta
+∞
16.7
16
*
CHC05
NOMESCO Finland
Iridotomy
7.5
16.6
24
33
L04AD01
ATC
ciclosporin; systemic
6.3
16.5
28
46
B02
ICD-10 Finland
Zoster [herpes zoster]
3.5
16.2
58
176
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.6
16.1
105
446
K50.8
ICD-10 Finland
Other Crohn disease
6.2
15.7
27
45
4AA12, ,
NOMESCO Finland
26.9
15.7
21
8
NF1AA
NOMESCO Finland
Hip X-ray examination
2.7
15.3
89
357
H35.36
ICD-10 Finland
Macular cyst
29.3
15.2
20
7
S01BC05
ATC
ketorolac; ophthalmic
4.0
15.0
44
116
ZX120
NOMESCO Finland
Intravenous
2.6
15.0
92
379
UJF32
NOMESCO Finland
Coloscopy
2.0
14.9
215
1264
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
4.1
14.9
42
108
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
14.7
242
1485
L04AC10
ATC
secukinumab; parenteral
21.6
14.7
21
10
N02AX02
ATC
tramadol; systemic, rectal
1.8
14.7
344
2362
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
5.8
14.7
27
48
N02BF02
ATC
pregabalin; oral
2.9
14.6
70
253
H21.1
ICD-10 Finland
Other vascular disorders of iris and ciliary body
+∞
14.6
14
*
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
152.8
14.5
15
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
4.2
14.1
38
94
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.6
14.1
27
50
S01EC03
ATC
dorzolamide; ophthalmic
11.2
14.1
26
24
TCG10
NOMESCO Finland
Removal of sutures from cornea
54.4
13.9
16
*
S01FA06
ATC
tropicamide; ophthalmic
54.4
13.9
16
*
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
54.4
13.9
16
*
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
3.4
13.8
50
153
D86
ICD-10 Finland
Sarcoidosis
76.6
13.6
15
*
H17.9
ICD-10 Finland
Corneal scar and opacity, unspecified
+∞
13.6
13
*
R4110
NOMESCO Finland
Physiotherapy
1.9
13.5
230
1421
M05BA04
ATC
alendronic acid; oral
2.6
13.3
80
326
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
4.3
13.3
34
81
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
5.1
13.2
28
57
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.2
13.0
54
180
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
5.2
12.8
26
51
TNG10
NOMESCO Finland
Puncture of knee
6.3
12.5
21
34
S01EE03
ATC
bimatoprost; ophthalmic
5.0
12.5
27
56
H43.1
ICD-10 Finland
Vitreous haemorrhage
5.0
12.5
27
56
Z3226
NOMESCO Finland
Physiotherapist
2.0
12.3
152
839
XCH00
NOMESCO Finland
Eye pressure measurement
3.2
12.2
49
160
R4180
NOMESCO Finland
Podiatric therapy
6.1
12.2
21
35
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.7
12.2
69
273
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
12.7
12.2
21
17
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
12.7
12.2
21
17
4AB02, ,
NOMESCO Finland
21.7
12.0
17
8
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
12.0
331
2345
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
11.8
270
1811
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.8
11.8
236
1524
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.9
11.6
34
90
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
3.1
11.5
48
160
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
5.8
11.5
21
37
WX002
NOMESCO Finland
Sedation and analgesia
2.0
11.5
151
850
H13.1*B02.3
ICD-10 Finland
Zoster conjunctivitis
+∞
11.5
11
*
H16.8
ICD-10 Finland
Other keratitis
121.8
11.5
12
*
H40.9
ICD-10 Finland
Glaucoma, unspecified
5.2
11.3
23
45
M01CB01
ATC
sodium aurothiomalate; parenteral
9.8
11.3
22
23
H15.1
ICD-10 Finland
Episcleritis
17.4
11.2
17
10
K50.0
ICD-10 Finland
Crohn disease of small intestine
5.7
11.2
21
38
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
2.7
11.1
60
232
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
4.7
10.8
25
55
M01AX01
ATC
nabumetone; oral
3.1
10.7
44
146
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.1
10.6
110
568
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
14.5
10.5
17
12
H26.02
ICD-10 Finland
Presenil cataract
4.2
10.5
28
69
H19.2
ICD-10 Finland
Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere
+∞
10.4
10
*
H22.0*A69.2
ICD-10 Finland
Iridocyclitis in Lyme disease
+∞
10.4
10
*
CS494
NOMESCO Finland
Other visual field testing
4.1
10.3
28
70
XCD10
NOMESCO Finland
Electrophysiological examination of eye
4.6
10.3
24
53
E0000UV, ,
ATC
1.7
10.3
319
2305
UJF30
NOMESCO Finland
Ileoscopy through colon
2.2
10.3
88
421
M08.9
ICD-10 Finland
Juvenile arthritis, unspecified
23.7
10.3
14
6
M01AC06
ATC
meloxicam; systemic, rectal
1.7
10.2
274
1907
S01EX03, ,
ATC
5.4
10.2
20
38
N02BE01
ATC
paracetamol; systemic, rectal
2.2
10.1
672
5964
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.0
10.1
45
156
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
4.9
10.1
22
46
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.6
10.0
33
95
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
2.5
9.9
64
270
G53.0*B02.20
ICD-10 Finland
Trigeminal neuralgia after shingles
17.0
9.9
15
9
ZXA05
NOMESCO Finland
Left side
1.8
9.7
183
1150
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.3
9.7
36
112
J01DB01
ATC
cefalexin; oral
1.9
9.7
619
5365
NG1DA
NOMESCO Finland
X-ray of knees
4.4
9.6
24
56
Z2446
NOMESCO Finland
Social worker
2.4
9.6
65
280
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
8.5
9.6
20
24
G53.0
ICD-10 Finland
Postzoster neuralgia
11.6
9.6
17
15
XX9XE
NOMESCO Finland
Other ultrasound examination
10.2
9.6
18
18
N03AX12
ATC
[U] gabapentin; oral
1.9
9.4
130
742
3641A
ICD-9 Finland
Disorders of iris and ciliary body, Chronic iridocyclitis
+∞
9.4
9
*
7143D
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[OLIGARTHRITIS JUVENILIS]
+∞
9.4
9
*
UJF92
NOMESCO Finland
Capsular endoscopy
4.4
9.4
23
53
D86.3
ICD-10 Finland
Sarcoidosis of skin
22.0
9.4
13
6
A04AA01
ATC
ondansetron; systemic, rectal
2.3
9.3
72
330
M01AB01
ATC
indometacin; systemic, rectal
2.5
9.2
60
254
L04AA06
ATC
mycophenolic acid; systemic
4.2
9.2
24
58
H11.3
ICD-10 Finland
Conjunctival haemorrhage
2.9
9.2
43
154
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
9.1
287
2067
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.2
9.1
81
394
EG1AA
NOMESCO Finland
Mandibular joint X-ray examination
15.8
9.1
14
9
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.9
9.0
26
68
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.8
9.0
27
73
ZXD05
NOMESCO Finland
Urgent procedure
1.7
8.9
226
1537
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
8.9
159
981
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
8.9
196
1285
L04AK01
ATC
leflunomide; oral
12.7
8.9
15
12
S01EC54
ATC
brinzolamide, combinations; ophthalmic
8.1
8.9
19
24
CJD20
NOMESCO Finland
Extracapsular cataract extraction with implantation of artificial lens in posterior chamber
50.6
8.7
10
*
H03.1*B00.5
ICD-10 Finland
Herpesviral dermatitis of eyelid
50.6
8.7
10
*
L40.5
ICD-10 Finland
Arthropathic psoriasis
4.6
8.6
20
44
CG2T4
NOMESCO Finland
Topography assessment of cornea
16.5
8.6
13
8
Z3231
NOMESCO Finland
Registered nurse
1.7
8.5
207
1391
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.5
8.5
52
214
J31.0
ICD-10 Finland
Chronic rhinitis
2.2
8.5
74
357
H40.6
ICD-10 Finland
Glaucoma secondary to drugs
91.0
8.4
9
*
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
5.0
8.4
18
37
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
8.4
77
379
H16.3
ICD-10 Finland
Interstitial and deep keratitis
+∞
8.3
8
*
H21.0
ICD-10 Finland
Hyphaema
+∞
8.3
8
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
8.3
86
443
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.3
8.2
66
307
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
8.2
267
1926
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
8.3
8.1
17
21
H16.2
ICD-10 Finland
Keratoconjunctivitis
33.7
8.1
10
*
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
3.7
8.1
25
69
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.1
8.1
74
364
J01FA06
ATC
roxithromycin; oral
1.6
8.1
281
2059
T85.2
ICD-10 Finland
Mechanical complication of intraocular lens
22.3
8.0
11
5
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
22.3
8.0
11
5
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.5
8.0
27
79
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
7.9
296
2204
H02AB04
ATC
methylprednisolone; systemic
1.9
7.8
108
615
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
7.8
191
1284
H33.0
ICD-10 Finland
Retinal detachment with retinal break
3.3
7.7
29
91
L28
ICPC
Limited function/disability (L)
1.8
7.7
142
882
B00.10
ICD-10 Finland
Herpes simplex facialis
7.5
7.7
17
23
H10.8
ICD-10 Finland
Other conjunctivitis
7.5
7.7
17
23
R50.9
ICD-10 Finland
Fever, unspecified
1.8
7.7
121
718
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.5
7.7
49
206
J01MA12
ATC
levofloxacin; systemic
1.8
7.6
133
813
RT160, ,
NOMESCO Finland
18.6
7.6
11
6
CD2S4
NOMESCO Finland
Photography of eye
12.0
7.6
13
11
Z2221
NOMESCO Finland
Medical doctor
1.6
7.6
197
1341
NAJ12
NOMESCO Finland
Posterior reduction of fracture of cervical spine
25.3
7.6
10
*
K50.1
ICD-10 Finland
Crohn disease of large intestine
6.3
7.6
19
31
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.2
7.6
63
298
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.8
7.5
37
136
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
7.2
7.5
17
24
R05
ICD-10 Finland
Cough
1.7
7.5
163
1061
H18.1
ICD-10 Finland
Bullous keratopathy
80.9
7.4
8
*
M08.1
ICD-10 Finland
Juvenile ankylosing spondylitis
80.9
7.4
8
*
L04AA24
ATC
abatacept; parenteral
13.5
7.4
12
9
RT272, ,
NOMESCO Finland
13.5
7.4
12
9
H01.0
ICD-10 Finland
Blepharitis
2.3
7.4
56
255
A07EA06
ATC
budesonide; oral, local oral
2.7
7.3
38
144
R4120
NOMESCO Finland
Occupational therapy
2.3
7.3
57
262
H30.8
ICD-10 Finland
Other chorioretinal inflammations
+∞
7.3
7
*
CGG31
NOMESCO Finland
Posterior corneal lamellar transplantation
+∞
7.3
7
*
H18.5
ICD-10 Finland
Hereditary corneal dystrophies
+∞
7.3
7
*
D07AC01
ATC
betamethasone; topical
1.6
7.3
262
1923
A02BC03
ATC
lansoprazole; oral
1.6
7.3
206
1430
TAB00
NOMESCO Finland
Lumbar puncture
2.5
7.2
44
181
R06.0
ICD-10 Finland
Dyspnoea
1.6
7.2
200
1382
CG2X4
NOMESCO Finland
Optical coherence tomography (OCT) of cornea
30.3
7.2
9
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.0
7.1
81
431
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
6.7
7.1
17
26
S12.2
ICD-10 Finland
Fracture of other specified cervical vertebra
6.7
7.1
17
26
M13.0
ICD-10 Finland
Polyarthritis, unspecified
6.7
7.1
17
26
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
7.1
315
2416
H35.9
ICD-10 Finland
Retinal disorder, unspecified
12.2
7.1
12
10
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
12.2
7.1
12
10
CHD65
NOMESCO Finland
Nonpenetrating glaucoma surgery
8.9
7.1
14
16
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
5.9
6.9
18
31
R06AE07
ATC
cetirizine; oral
1.5
6.9
307
2352
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
4.0
6.9
19
48
ZXA00
NOMESCO Finland
Right side
1.6
6.9
192
1325
SBB10
NOMESCO Finland
Dental impressions
2.1
6.9
64
316
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.2
6.9
61
296
M01AH02
ATC
rofecoxib; oral
1.9
6.8
96
549
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3.1
6.8
28
93
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
6.8
315
2436
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.5
6.7
40
163
K07.60
ICD-10 Finland
Snapping jaw
2.3
6.7
48
213
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.5
6.6
41
170
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.4
6.6
45
195
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
3.5
6.6
22
64
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.1
6.6
62
308
M16.7
ICD-10 Finland
Other secondary coxarthrosis
8.8
6.6
13
15
M01AE02
ATC
naproxen; oral, rectal
1.5
6.6
417
3426
M01CB03
ATC
auranofin; oral
10.1
6.5
12
12
N18.8
ICD-10 Finland
Other chronic renal failure
3.7
6.5
20
55
K50.9
ICD-10 Finland
Crohn disease, unspecified
4.0
6.5
18
46
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
6.4
48
217
AA1AD
NOMESCO Finland
CT of head and brain
1.6
6.4
206
1468
SPAT1263
SPAT
Sampling
1.5
6.4
298
2297
N06AX21
ATC
duloxetine; oral
1.9
6.4
88
501
CHD15
NOMESCO Finland
Trabeculectomy and iridectomy
8.2
6.3
13
16
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
3.6
6.3
20
56
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
9.4
6.3
12
13
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.6
6.3
35
138
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
6.3
523
4520
J01FF01
ATC
clindamycin; systemic
1.6
6.3
192
1353
H20.2
ICD-10 Finland
Lens-induced iridocyclitis
+∞
6.3
6
*
H220, M084,
ICD-10 Finland
+∞
6.3
6
*
H30.1
ICD-10 Finland
Disseminated chorioretinal inflammation
+∞
6.3
6
*
S01FB01
ATC
phenylephrine; ophthalmic
+∞
6.3
6
*
L04AC21
ATC
bimekizumab; systemic
+∞
6.3
6
*
M08.8
ICD-10 Finland
Other juvenile arthritis
+∞
6.3
6
*
Z94.7
ICD-10 Finland
Corneal transplant status
+∞
6.3
6
*
4AA17, ,
NOMESCO Finland
+∞
6.3
6
*
ZXD00
NOMESCO Finland
Emergency procedure
3.1
6.2
25
82
F01
ICPC
Eye pain
3.0
6.2
27
93
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
2.5
6.2
37
151
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.3
6.2
44
195
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.5
6.2
392
3205
B01AB05
ATC
enoxaparin; parenteral
1.5
6.2
218
1585
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
6.1
67
353
CHD35
NOMESCO Finland
Laser goniopuncture
12.6
6.1
10
8
M02AA07
ATC
piroxicam; topical
1.5
6.1
243
1813
RS221, ,
NOMESCO Finland
3.9
6.0
17
44

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
54
15
38.70
87.04
1.8
1.8
109.89
—
au/ml
—
9
0
470
2240
3.92
73.06
13.8
6.6
—
—
—
0
0
590
3436
4.30
64.68
15.5
6.5
0.04
0.04
e9/l
0.12
555
2956
594
3499
4.29
63.46
15.6
6.5
1.92
1.90
e9/l
0.06
562
3088
587
3430
4.21
63.46
15.6
6.5
0.61
0.58
e9/l
2.38
552
2947
595
3536
4.24
62.07
15.8
6.8
0.19
0.19
e9/l
0.40
562
3094
543
3165
3.56
55.37
15.8
6.5
2.86
2.89
%
0.09
531
2976
543
3168
3.55
55.22
16.2
6.6
9.27
8.85
%
3.28
531
2985
542
3165
3.53
54.89
16.2
6.6
0.72
0.68
%
1.27
530
2970
607
3808
4.05
54.84
17.5
9.9
3.99
4.10
e9/l
0.64
572
3325
544
3192
3.53
54.48
15.3
6.5
57.00
57.20
%
0.15
535
3052
547
3246
3.50
53.21
15.7
6.6
28.01
27.83
%
0.14
536
3085
173
575
3.61
43.41
5.3
4.7
0.39
0.56
%
0.79
49
184
176
599
3.53
42.51
5.9
4.9
0.63
0.97
%
1.14
52
199
170
568
3.57
42.22
6.1
5.0
0.09
0.12
%
0.29
46
166
169
580
3.47
40.11
6.2
5.3
0.02
0.16
%
1.17
44
153
486
2990
2.76
38.60
21.1
11.5
0.00
0.00
e9/l
0.43
435
2446
65
110
6.37
37.43
4.1
3.1
4.07
4.34
e9/l
0.42
65
110
306
1530
2.68
36.51
9.5
4.8
—
—
—
0
0
660
4981
3.61
32.51
14.1
8.3
80.93
79.64
u/l
0.17
637
4731
39
43
9.51
32.37
2.1
1.5
28.08
30.77
%
0.13
24
30
524
3555
2.55
30.72
5.7
3.9
0.02
0.45
estimate
0.48
149
689
522
3536
2.55
30.69
5.8
3.9
0.00
6.67
estimate
1.07
155
736
69
149
5.00
30.50
4.1
2.9
57.04
58.05
%
0.27
69
149
516
3498
2.51
29.93
5.7
3.9
0.00
0.00
estimate
0.50
153
724
89
250
3.90
28.03
1.1
1.1
—
—
—
0
0
57
118
5.14
26.41
2.2
1.6
—
—
—
0
0
597
4451
2.64
26.31
7.4
4.6
—
3.58
—
0
7
198
938
2.51
24.92
1.5
1.3
394.72
492.87
titre
0.66
53
202
183
852
2.52
23.78
3.8
3.2
4.07
5.19
e9/l
0.97
161
745
133
532
2.82
23.40
3.4
2.8
11.10
10.66
g/l
0.51
124
491
37
57
6.77
23.20
1.8
2.1
1130.13
1173.86
e6/l
0.10
32
49
426
2849
2.14
22.75
4.7
3.5
6.23
6.21
ph
0.11
220
1629
132
537
2.77
22.44
2.2
3.1
66.65
66.83
g/l
0.09
121
498
433
2957
2.09
21.35
3.2
2.5
74.84
76.50
nmol/l
0.63
403
2669
382
2491
2.08
21.34
5.2
4.0
77.21
104.58
e6/l
0.36
273
1758
324
2004
2.08
20.72
10.3
6.3
—
—
—
0
0
38
68
5.83
20.57
2.3
1.7
55.95
58.67
%
0.13
22
52
317
1982
2.03
19.34
5.2
4.2
7.40
7.40
ph
0.09
232
1410
429
2988
2.01
19.23
8.2
7.1
1.22
1.21
mmol/l
1.86
399
2762
350
2281
2.00
18.86
3.4
3.5
2.36
2.35
mmol/l
0.01
330
2067
121
513
2.62
18.79
6.2
3.9
—
—
—
0
0
72
230
3.36
18.57
1.3
1.2
—
—
—
0
0
108
436
2.72
18.47
1.9
2.6
—
—
—
0
0
309
1955
1.98
17.88
6.5
4.0
0.00
0.01
estimate
1.15
145
673
106
431
2.70
17.86
2.1
1.7
1.42
1.54
g/l
0.15
99
399
413
2888
1.95
17.75
5.5
5.3
35.77
35.81
g/l
0.06
392
2712
280
1717
2.00
17.67
3.0
2.3
3.23
2.90
mg/l
1.27
248
1485
459
3330
1.97
17.65
9.0
7.7
1.22
1.21
mmol/l
2.30
382
2899
78
277
3.03
16.85
1.7
1.9
6.36
7.55
iu/ml
0.22
17
62
27
19
14.69
16.42
2.9
5.9
6.51
10.73
mg/l
1.78
16
19
39
90
4.52
15.85
1.1
1.2
—
—
—
0
0
468
3507
1.88
15.31
6.5
6.9
11.61
11.77
umol/l
0.06
444
3348
25
18
14.32
15.10
2.0
1.4
6.17
1.80
%
—
6
5
720
6383
3.84
15.03
29.1
15.6
20.87
24.16
mg/l
2.38
658
5226
539
4242
1.95
15.01
5.9
4.7
517.00
2597.81
e6/l
—
10
75
99
440
2.44
13.76
2.8
2.4
15.88
16.39
au/ml
0.03
12
40
239
1501
1.87
13.31
3.4
2.7
4.37
5.77
e6/l
0.84
229
1370
159
870
2.05
13.28
3.9
2.6
140.60
127.27
ug/g
0.17
129
698
91
396
2.48
13.23
1.5
1.3
55.18
53.84
au/ml
—
5
29
318
2186
1.79
13.12
4.1
3.4
48.19
89.16
e6/l
0.59
264
1666
113
544
2.27
13.07
1.5
1.6
—
—
—
0
0
143
766
2.07
12.60
2.5
1.6
—
—
—
0
0
177
1039
1.92
11.97
3.0
2.5
2.31
2.34
g/l
0.29
162
974
277
1873
1.76
11.79
4.1
3.2
0.31
0.48
e6/l
1.01
221
1360
23
45
5.24
11.32
2.2
2.1
466.11
503.03
e6/l
0.17
18
35
146
820
1.97
11.19
1.8
1.7
—
—
—
0
0
182
1109
1.85
10.85
3.1
2.6
12.74
13.18
umol/l
0.33
166
1040
67
278
2.55
10.75
1.7
2.1
1.34
1.46
g/l
0.56
57
249
364
2701
1.67
10.73
5.8
3.8
0.01
0.02
estimate
0.61
128
605
175
1062
1.84
10.54
1.7
1.7
—
—
—
0
0
201
1273
1.79
10.52
1.9
2.0
—
—
—
0
0
266
1827
1.70
10.43
6.4
4.2
—
—
—
0
0
123
666
2.01
10.41
2.4
2.1
336.08
379.56
nmol/l
1.54
118
627
280
1954
1.69
10.32
4.8
3.3
0.15
0.05
estimate
0.29
131
584
100
503
2.14
10.31
4.4
4.2
91.17
82.08
ng/l
0.49
89
446
27
66
4.21
10.23
1.3
2.2
—
—
—
0
0
624
5398
1.90
10.13
33.2
19.6
13.88
13.60
%
5.54
619
5339
154
909
1.87
10.09
1.3
1.2
—
—
—
0
0
270
1881
1.68
9.94
3.5
3.0
0.20
0.05
—
5
38
728
6715
3.44
9.82
24.5
12.0
25.51
26.62
u/l
0.90
712
6537
341
2528
1.64
9.80
4.6
3.7
30.65
59.64
ng/l
0.68
242
1794
161
972
1.83
9.79
2.9
2.1
—
—
—
0
0
49
182
2.81
9.76
2.1
1.6
11765.79
15155.54
e6/l
0.22
38
133
159
967
1.82
9.41
3.2
2.5
22.78
22.66
%
0.04
147
916
214
1419
1.71
9.38
1.7
1.5
2.66
2.42
g/l
0.68
141
874
26
67
3.98
9.20
1.3
1.4
—
—
—
0
0
201
1318
1.72
9.15
3.6
2.9
530.37
539.98
mosm/kgh2o
0.28
184
1155
149
898
1.82
9.06
7.2
6.5
1.02
1.04
mmol/l
0.41
143
827
131
760
1.88
8.99
3.0
2.9
1.91
1.78
%
0.75
114
696
385
3010
1.57
8.42
20.3
13.5
1.29
1.23
inr
1.01
325
2506
474
3889
1.59
8.39
5.9
5.4
6.58
6.65
mmol/l
0.32
459
3693
165
1052
1.73
8.22
1.9
1.7
1303.93
1175.93
nmol/l
0.96
122
792
707
6501
2.40
8.18
25.9
18.6
139.38
139.67
mmol/l
2.59
701
6372
707
6510
2.38
7.99
26.3
18.7
3.95
3.97
mmol/l
1.42
701
6370
38
139
2.83
7.82
1.5
1.7
—
—
—
0
0
276
2026
1.57
7.79
2.2
2.2
183.62
271.38
u/l
0.93
258
1926
93
506
1.96
7.70
3.9
3.8
1.24
1.23
mmol/l
0.87
79
437
393
3129
1.53
7.64
4.1
3.1
129.30
121.85
ug/l
0.30
368
2939
15
17
8.98
7.57
1.5
1.9
25.20
29.59
%
0.42
15
17
67
332
2.12
7.16
2.7
2.1
0.00
0.04
estimate
0.68
27
111
195
1342
1.61
7.14
2.0
1.8
453.24
24205371.76
pmol/l
1.18
161
1132
34
124
2.82
7.05
2.7
2.9
8.60
8.51
pmol/l
0.02
34
124
105
612
1.83
7.04
2.6
2.1
0.00
0.02
estimate
0.50
29
139
231
1659
1.57
7.04
2.8
2.9
344.33
345.30
umol/l
0.05
207
1477
83
448
1.96
7.03
1.4
1.3
137.22
198.70
u/ml
0.59
76
417
709
6589
2.27
6.92
22.2
14.0
—
—
—
0
0
28
93
3.09
6.83
1.9
2.7
—
—
—
0
0
124
768
1.74
6.77
1.6
1.4
—
—
—
0
0
47
206
2.37
6.75
1.9
4.2
37.40
39.86
mg/l
0.09
36
179
47
206
2.37
6.75
2.0
4.1
54.26
79.35
mg/l
0.38
35
177
40
163
2.54
6.71
1.6
1.7
1719.36
837.56
e6/l
0.22
28
128
87
485
1.90
6.70
5.0
3.3
—
—
—
0
0
264
1977
1.52
6.56
3.7
3.2
—
—
—
0
0
299
2298
1.50
6.56
4.0
3.5
29.37
33.92
u/l
2.21
275
2177
736
6977
3.30
6.55
42.1
23.8
258.47
250.24
e9/l
2.83
728
6841
736
6980
3.28
6.49
42.0
23.8
4.41
4.51
e12/l
5.86
727
6823
736
6980
3.28
6.49
42.0
23.8
6.83
6.72
e9/l
0.65
729
6820
99
584
1.80
6.37
3.4
2.7
67.05
70.47
e9/l
0.49
77
443
185
1293
1.57
6.25
2.7
2.9
2.46
2.45
mmol/l
0.63
167
1170
38
160
2.45
5.97
1.4
1.6
6.81
8.78
e6/l
0.16
26
122
253
1912
1.49
5.89
2.0
1.7
21.25
20.45
nmol/l
0.34
215
1617
255
1935
1.48
5.80
3.7
3.3
1476.39
1215.90
ng/l
0.54
220
1650
179
1261
1.55
5.80
1.4
1.3
29.61
33.12
iu/ml
0.09
39
389
129
853
1.62
5.45
1.8
1.5
—
—
—
0
0
13
21
6.28
5.40
2.4
2.1
0.14
0.51
e9/l
—
8
8
40
182
2.26
5.32
2.9
3.2
8.78
2.17
index
0.36
23
111
16
35
4.65
5.20
1.1
1.2
—
—
—
0
0
25
94
2.72
4.95
2.0
3.7
1.22
0.88
%
0.37
25
87
45
222
2.09
4.92
2.2
2.2
10.42
10.44
g/l
0.01
39
203
10
13
7.78
4.86
1.1
1.5
—
—
—
0
0
36
164
2.26
4.79
1.2
1.5
—
—
—
0
0
18
57
3.21
4.79
2.7
2.8
41.00
39.68
%
0.09
11
29
18
58
3.15
4.66
1.1
1.2
—
—
—
0
0
269
2131
1.41
4.65
3.0
2.7
54.06
60.68
u/l
1.80
253
1994
348
2880
1.39
4.64
2.3
2.1
95.56
96.48
pmol/l
0.11
195
1534
153
1097
1.50
4.48
2.7
3.8
0.82
0.82
mmol/l
0.07
142
1044
287
2317
1.39
4.38
3.5
3.4
7.62
7.75
mmol/l
0.16
241
1985
22
84
2.67
4.26
2.7
1.9
31.41
33.17
pg
1.01
22
84
367
3092
1.36
4.26
2.9
2.8
—
—
estimate
—
0
0
46
242
1.96
4.25
2.5
2.6
—
—
—
0
0
28
121
2.36
4.22
3.9
4.3
2.52
2.28
mmol/l
0.18
22
78
14
42
3.38
4.06
1.4
1.1
0.68
0.52
ratio
—
9
24
41
211
2.00
4.04
1.8
1.6
1.18
1.18
g/l
0.07
41
200
195
1493
1.41
4.01
1.7
1.8
1.15
1.26
mg/l
0.23
148
1155
310
2561
1.36
4.01
2.1
2.2
—
—
—
0
0
16
53
3.06
3.98
2.2
1.2
109.75
109.45
pmol/l
0.01
16
53
18
64
2.86
3.98
1.1
1.2
—
—
—
0
0
13
32
4.12
3.91
1.1
1.1
1490.69
1641.38
miu/ml
0.19
13
32
48
266
1.86
3.83
1.2
1.3
—
—
—
0
0
157
1166
1.44
3.80
3.3
3.0
0.84
1.00
e6/l
0.45
93
618
119
837
1.50
3.80
1.3
1.3
—
—
—
0
0
29
135
2.19
3.72
5.6
3.4
—
—
—
0
0
37
190
2.00
3.69
2.1
3.9
1.39
2.76
ratio
1.71
18
116
639
5954
1.48
3.67
5.2
5.3
1.87
1.92
mu/l
0.49
598
5519
96
654
1.54
3.56
1.5
1.8
—
—
—
0
0
21
90
2.37
3.27
2.7
1.8
1.07
0.86
%
0.48
15
63
551
5040
1.35
3.24
4.2
4.3
14.99
14.76
pmol/l
1.56
512
4634
13
39
3.37
3.23
1.2
2.2
85.00
93.51
ng/l
0.19
13
39
263
2179
1.32
3.16
2.8
2.4
—
—
—
0
0
21
92
2.32
3.12
3.3
2.6
—
—
—
0
0
72
476
1.57
3.07
3.6
4.0
7.42
7.42
ph
0.39
58
397
256
2123
1.31
3.03
3.7
3.5
56.48
48.98
mg/l
0.16
161
1372
63
405
1.61
3.02
2.9
3.8
4.29
4.67
pmol/l
2.77
57
361
19
81
2.38
3.00
1.2
1.3
—
—
—
0
0
201
1613
1.34
3.00
6.1
4.0
1.02
1.02
kg/l
0.58
160
1066
17
69
2.50
2.97
2.1
3.6
—
—
—
0
0
28
143
1.99
2.88
4.1
2.4
90.03
89.57
%
0.14
28
137
151
1170
1.36
2.82
1.4
1.3
12.00
12.89
u/ml
0.05
52
433
258
2168
1.29
2.72
4.8
4.2
8.36
8.73
mg/mmol
0.04
167
1371
15
60
2.53
2.71
1.1
1.2
—
—
—
0
0
16
67
2.42
2.64
2.8
2.3
—
—
—
0
0
105
777
1.41
2.59
3.1
3.3
11.85
7.93
umol/l
0.51
87
692
632
5974
1.36
2.48
6.9
6.3
39.07
39.16
mmol/mol
0.09
594
5636
12
45
2.69
2.46
1.1
1.1
—
—
—
0
0
49
313
1.60
2.45
2.2
2.3
—
—
—
0
0
9
28
3.24
2.31
6.1
3.0
22.59
334.80
ug/l
—
9
22
80
578
1.43
2.27
6.2
4.2
7.38
7.36
ph
0.41
61
416
7
18
3.91
2.25
2.1
1.2
0.61
0.49
e9/l
—
7
18
30
173
1.76
2.20
1.3
1.2
—
—
—
0
0
44
283
1.59
2.16
1.4
1.2
—
—
—
0
0
198
1652
1.27
2.15
5.2
4.3
86.64
90.26
%
1.19
187
1625
101
768
1.36
2.13
8.1
8.7
1.29
0.97
mmol/l
0.37
82
640
86
638
1.39
2.11
3.1
2.6
33.80
34.93
u/l
0.08
69
545
29
169
1.74
2.07
1.2
1.3
207.48
234.42
u/ml
0.26
14
98
39
249
1.60
1.99
4.0
3.6
329.00
286.32
mg/l
0.09
18
111
8
27
2.98
1.94
1.6
1.7
—
—
—
0
0
100
773
1.34
1.91
8.1
8.7
7.42
7.42
ph
0.10
49
441
135
1090
1.29
1.89
3.9
3.1
2.44
2.34
e6/l
0.06
73
538
152
1247
1.27
1.88
4.5
3.9
427.75
430.98
ng/l
0.00
124
959
193
1629
1.25
1.88
2.7
2.4
—
—
—
0
0
8
28
2.88
1.86
1.1
2.1
41.55
41.09
g/l
—
8
28
479
4441
1.22
1.82
3.7
3.4
48.06
48.85
u/l
0.07
441
4201
85
647
1.35
1.81
2.3
2.5
0.21
0.21
g/l
0.02
80
612
12
54
2.24
1.74
1.7
2.8
1206.42
858.04
mg
0.20
12
54
48
333
1.47
1.72
1.4
1.2
—
—
—
0
0
88
679
1.34
1.72
1.7
1.5
—
—
—
0
0
5
13
3.86
1.71
1.4
2.1
3.60
2.31
%
—
5
13
5
13
3.86
1.71
1.8
4.6
—
—
—
0
0
14
68
2.08
1.71
1.9
1.7
—
—
—
0
0
14
68
2.08
1.71
1.9
1.4
—
—
—
0
0
10
40
2.52
1.67
1.1
1.8
—
—
—
0
0
10
43
2.34
1.59
1.3
1.4
4.54
8.17
u/l
—
10
36
661
6376
1.30
1.57
5.9
5.7
2.63
2.71
mmol/l
1.29
613
5948
98
779
1.30
1.56
8.3
8.6
11.71
12.26
kpa
0.61
93
755
5
15
3.35
1.52
1.2
1.3
—
—
—
0
0
84
657
1.31
1.51
9.2
9.3
121.51
120.44
g/l
0.19
84
642
637
6123
1.26
1.51
5.1
5.1
5.96
5.92
mmol/l
0.26
576
5639
190
1642
1.21
1.46
1.4
1.3
1.62
1.61
u/ml
0.00
59
464
74
572
1.33
1.45
1.5
1.4
—
—
—
0
0
5
16
3.14
1.44
1.6
4.3
66.30
49.41
%
—
5
16
15
81
1.87
1.41
1.5
2.1
—
—
—
0
0
15
81
1.87
1.41
1.4
2.8
11.46
9.20
umol/l
—
7
58
9
40
2.26
1.40
1.1
1.1
—
—
—
0
0
301
2720
1.18
1.40
2.1
2.0
1.40
1.35
mmol/l
0.47
245
2314
15
82
1.85
1.36
1.3
1.2
—
—
—
0
0
5
17
2.95
1.36
1.0
1.0
—
—
—
0
0
78
615
1.30
1.34
12.2
9.9
—
—
—
0
0
22
136
1.64
1.34
1.3
1.8
—
—
—
0
0
39
276
1.44
1.31
3.1
4.9
25.27
24.97
mmol/l
0.18
32
259
18
107
1.70
1.26
1.1
1.2
—
—
—
0
0
229
2047
1.17
1.19
5.7
5.3
2.99
2.35
ug/l
0.39
205
1866
13
72
1.82
1.15
1.2
1.1
—
—
—
0
0
8
39
2.06
1.15
1.9
1.6
—
—
—
0
0
213
1901
1.17
1.13
1.4
1.5
—
—
—
0
0
90
741
1.24
1.12
1.5
1.5
—
—
—
0
0
646
6265
1.22
1.11
5.2
5.0
1.48
1.46
mmol/l
0.62
594
5841
7
31
2.27
1.10
1.1
1.2
133.86
180.34
iu/ml
—
7
31
619
5984
1.19
1.08
4.3
4.3
1.27
1.29
mmol/l
0.32
565
5535
36
263
1.39
1.05
1.4
1.6
844.39
928.15
mu/l
0.37
30
225
12
67
1.80
1.05
1.9
1.4
1068.29
1923.07
e6/l
—
7
43
12
68
1.78
1.01
3.2
3.2
17.50
14.12
index
—
6
51
647
6291
1.20
0.99
5.3
5.1
4.56
4.63
mmol/l
0.93
598
5891
15
93
1.63
0.94
1.0
1.1
1.80
7.75
u/ml
—
10
43
6
28
2.15
0.91
2.2
1.3
—
—
—
0
0
11
64
1.73
0.86
3.5
2.6
—
—
—
0
0
140
1241
1.16
0.82
3.6
3.1
0.71
0.78
ug/l
0.41
104
767
16
235
0.67
0.80
1.1
1.2
0.96
0.91
g/l
0.39
16
235
10
58
1.73
0.80
1.8
1.4
—
—
—
0
0
6
33
1.82
0.79
4.2
2.3
—
—
—
0
0
22
303
0.72
0.78
1.5
1.7
—
—
—
0
0
19
132
1.45
0.76
1.4
1.1
—
—
—
0
0
18
124
1.46
0.75
1.2
1.1
—
—
—
0
0
13
83
1.58
0.75
1.5
1.3
0.53
0.62
nmol/l
0.63
13
78
13
83
1.58
0.75
1.6
1.2
—
—
—
0
0
31
237
1.32
0.73
3.1
2.1
7312.64
4830.16
u/l
0.17
16
96
5
25
2.01
0.72
1.4
2.9
0.60
0.59
mmol/l
—
5
25
11
68
1.63
0.72
1.1
1.1
—
—
—
0
0
5
26
1.93
0.70
1.2
1.2
—
800.00
—
0
6
9
58
1.56
0.70
1.1
1.1
—
—
—
0
0
43
348
1.25
0.68
3.0
4.4
—
—
—
0
0
24
179
1.35
0.67
1.5
2.1
2.01
5.29
iu/l
—
7
71
5
28
1.79
0.66
2.6
1.4
0.00
0.00
estimate
—
5
28
5
28
1.79
0.66
1.2
1.2
—
—
—
0
0
16
224
0.71
0.65
1.1
1.1
1.53
1.53
g/l
0.01
16
224
8
49
1.64
0.62
1.5
3.4
7.43
8.75
mmol/l
—
8
49
14
96
1.47
0.62
1.0
1.1
1.16
3.63
u/ml
—
9
47
29
228
1.28
0.59
1.8
1.6
321.92
294.21
mu/l
0.16
23
209
16
114
1.41
0.59
1.6
1.9
—
—
—
0
0
0
23
0.00
0.58
0.0
2.2
—
18.00
—
0
23
20
149
1.35
0.58
4.0
2.4
101.55
73.94
ug/min
0.23
11
92
14
98
1.44
0.57
1.4
1.4
16.65
24.85
u/l
0.68
14
83
64
552
1.17
0.56
1.2
1.2
—
—
—
0
0
11
73
1.51
0.56
1.3
1.4
2.11
2.94
ug/l
0.76
11
63
11
73
1.51
0.56
1.5
1.3
0.15
0.19
nmol/l
0.70
11
50
17
124
1.38
0.56
1.4
1.4
78.75
60.82
mmol/l
0.75
12
106
273
2576
1.09
0.56
3.3
3.1
—
—
—
0
0
24
186
1.30
0.55
1.4
1.5
255.60
280.10
ug/g
—
10
112
84
745
1.14
0.52
4.6
4.6
7.38
7.38
ph
0.05
48
441
24
188
1.29
0.51
1.4
1.2
—
—
—
0
0
61
529
1.17
0.51
1.9
2.4
4.20
7.93
ug/l
2.49
48
479
41
344
1.20
0.50
1.2
1.1
—
38.50
—
0
6
16
119
1.35
0.48
1.1
1.1
0.14
2.57
u/ml
—
10
65
55
476
1.17
0.48
3.5
3.1
150.20
202.31
ng/l
0.90
49
435
37
309
1.21
0.47
1.8
2.0
—
—
—
0
0
11
77
1.43
0.45
1.5
1.3
—
—
nmol/l
—
0
0
13
95
1.37
0.44
1.3
1.6
—
—
—
0
0
13
95
1.37
0.44
1.3
1.6
—
—
—
0
0
13
95
1.37
0.44
1.3
1.6
—
—
—
0
0
13
95
1.37
0.44
1.3
1.6
—
—
—
0
0
6
91
0.66
0.42
1.2
1.2
—
—
—
0
0
17
131
1.30
0.42
1.2
1.1
—
—
—
0
0
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
10
70
1.43
0.42
1.7
9.1
10.98
11.17
%
—
10
70
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
17
0.00
0.40
0.0
1.0
—
13.95
—
0
12
79
716
1.12
0.38
4.7
4.6
1.26
1.83
mmol/l
0.77
65
612
17
213
0.79
0.37
1.5
1.3
107.40
251.25
miu/ml
—
5
101
18
143
1.27
0.37
1.2
1.1
0.30
3.18
u/ml
—
10
82
10
72
1.39
0.37
7.5
3.7
3.01
5.70
nmol/l
—
10
72
11
81
1.36
0.36
1.4
1.4
15.29
26.77
ng/l
1.34
11
81
74
672
1.11
0.35
4.0
4.6
3.89
28.78
ug/l
1.34
61
561
6
43
1.40
0.35
1.5
1.3
—
—
—
0
0
57
510
1.13
0.34
3.0
2.5
6.03
6.12
ph
0.32
39
339
6
86
0.70
0.33
2.7
2.5
1.19
1.20
mmol/l
—
6
86
6
87
0.69
0.33
2.7
2.5
108.50
104.99
mmol/l
—
6
87
6
87
0.69
0.33
2.7
2.5
4.08
4.03
mmol/l
—
6
87
6
46
1.31
0.33
1.2
1.4
76.17
77.98
umol/l
—
6
46
44
391
1.13
0.30
4.2
3.9
0.61
0.63
%
0.11
44
391
29
250
1.17
0.30
1.6
1.5
—
—
—
0
0
25
292
0.85
0.29
2.8
4.6
0.94
0.87
%
0.43
25
272
7
56
1.25
0.29
1.1
1.2
—
—
—
0
0
7
57
1.23
0.29
1.3
1.1
—
—
—
0
0
11
85
1.30
0.28
2.5
1.8
—
—
—
0
0
14
172
0.81
0.27
3.4
4.5
—
—
—
0
0
28
321
0.87
0.27
2.6
4.4
1.41
1.55
%
0.56
28
302
11
139
0.79
0.27
4.1
6.3
11.27
11.35
mmol/l
0.02
11
124
11
139
0.79
0.27
4.1
6.3
102.64
104.90
mmol/l
0.68
11
124
8
66
1.21
0.26
1.0
1.1
—
—
—
0
0
10
77
1.30
0.26
2.3
2.1
13.30
13.04
%
—
10
77
15
123
1.22
0.25
1.1
1.0
9.11
4.83
u/ml
—
10
74
9
76
1.19
0.24
2.7
2.3
—
—
—
0
0
16
133
1.21
0.24
1.4
1.1
—
—
—
0
0
5
38
1.32
0.23
2.6
2.2
1.88
2.13
ug/l
—
5
32
15
125
1.20
0.22
1.4
1.6
—
—
—
0
0
5
42
1.19
0.21
1.0
1.3
11.42
24.56
umol/l
—
5
36
0
11
0.00
0.21
0.0
1.3
—
1.72
—
0
11
0
13
0.00
0.21
0.0
7.4
—
8.00
—
0
13
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
3.7
—
45.08
—
0
13
6
51
1.18
0.19
4.3
3.1
0.83
0.88
index
—
6
51
17
196
0.86
0.19
15.7
10.3
—
—
—
0
0
7
59
1.19
0.18
1.1
1.1
—
1.38
—
0
11
5
69
0.72
0.17
2.0
1.9
—
—
—
0
0
24
215
1.12
0.16
2.1
2.1
—
—
—
0
0
15
172
0.87
0.16
2.1
1.8
—
—
—
0
0
32
293
1.10
0.15
1.5
1.6
—
—
—
0
0
16
140
1.15
0.15
1.7
1.8
—
—
—
0
0
21
189
1.11
0.14
1.2
1.2
—
—
—
0
0
58
612
0.94
0.13
1.3
1.4
—
—
—
0
0
50
530
0.94
0.13
1.7
1.7
3.24
3.45
mmol/l
0.77
29
392
35
326
1.08
0.12
1.5
1.6
0.15
0.34
mg/l
2.43
14
154
11
127
0.86
0.12
1.4
1.6
—
—
—
0
0
15
168
0.89
0.11
1.2
1.3
—
—
—
0
0
15
134
1.12
0.11
1.4
1.1
—
—
—
0
0
14
125
1.12
0.10
1.4
1.5
—
—
—
0
0
25
232
1.08
0.10
2.1
1.8
39.92
40.13
nmol/l
0.02
25
223
5
46
1.09
0.09
2.0
3.5
16.64
16.47
%
—
5
46
10
87
1.15
0.09
1.0
1.0
0.24
0.76
u/ml
—
5
29
16
175
0.91
0.08
1.1
1.1
—
—
—
0
0
13
117
1.11
0.08
1.2
1.0
0.57
0.94
u/ml
—
8
55
7
64
1.09
0.08
1.1
2.8
—
—
—
0
0
30
315
0.95
0.06
1.6
1.6
—
—
—
0
0
30
313
0.96
0.05
1.6
1.6
—
—
—
0
0
48
489
0.98
0.02
1.1
1.2
47.50
141.91
u/ml
2.71
12
196
10
107
0.93
0.02
1.1
1.1
1.59
1.53
g/l
—
10
98
12
127
0.94
0.01
1.0
1.3
—
—
—
0
0
31
317
0.98
0.01
1.6
1.6
—
—
—
0
0
10
95
1.05
0.00
1.4
1.3
—
—
—
0
0
32
316
1.01
0.00
1.5
1.6
—
—
—
0
0
71
707
1.00
0.00
1.5
1.7
—
—
—
0
0
34
338
1.01
0.00
1.1
1.1
—
—
—
0
0
45
448
1.00
0.00
1.2
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
402.00
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
169.00
—
0
5
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
7.47
—
0
8
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
2.7
—
178.33
—
0
6
0
6
0.00
0.00
0.0
4.8
—
0.18
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.3
—
—
—
0
0
7
78
0.90
-0.00
1.3
1.1
—
—
titre
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
18
180
1.00
-0.00
1.9
1.8
219.72
220.42
pmol/l
0.02
18
170
0
7
0.00
-0.00
0.0
3.0
—
16.44
—
0
7
0
9
0.00
-0.00
0.0
1.6
—
59.11
—
0
9

Mortality – FinRegistry

↥

Association

Association between endpoint H7_IRIDOCYCLITISINOTH and mortality.

Females

Parameter HR [95% CI] p-value
H7_IRIDOCYCLITISINOTH 1.095 [0.91, 1.31] 0.326
Birth year 0.994 [0.99, 1.0] 0.156

During the follow-up period (1.1.1998 — 31.12.2019), 252 out of 1718 females with H7_IRIDOCYCLITISINOTH died.

Males

Parameter HR [95% CI] p-value
H7_IRIDOCYCLITISINOTH 1.374 [1.14, 1.66] 0.001
Birth year 0.985 [0.98, 0.99] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 266 out of 1621 males with H7_IRIDOCYCLITISINOTH died.

Mortality risk

Mortality risk for people of age

years, who have H7_IRIDOCYCLITISINOTH.

N-year risk Females Males
1 0.099% 0.265%
5 0.543% 1.506%
10 1.49% 3.577%
15 2.793% 6.832%
20 5.292% 11.356%

Relationships between endpoints

↥

Index endpoint: H7_IRIDOCYCLITISINOTH – Iridocyclitis in diseases classified elsewhere

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data